Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response
Dermatology · 2023 · 239 (3) · 454-461
DOI: 10.1159/000529301 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Dermatology, online erschienen am 30.01.2023. Verfasst von Oscar M Moreno-Arrones und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria …. Hauptthemen laut MEDLINE: Folliculitis, Alopecia, Hair Follicle. Die Arbeit wurde bisher 17-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Folliculitis decalvans (FD) is a rare primary neutrophilic scarring alopecia whose etiology has not been completely elucidated yet.
Objective
The aim of the study was to determine if the follicular microbiota residing in FD-affected hair follicles had a distinct microbiological signature and if an aberrant immune response was present in the pathogenesis of FD.
Methods
We conducted a cross-sectional study of 10 patients affected by FD. Trichoscopy-guided follicular biopsies were taken from affected and healthy scalp to identify the follicular microbiome using next-generation sequencing. We searched for microbiological biomarkers of FD-affected follicles using the linear discriminant analysis (LDA) effect size (LEfSe) tool. Additionally, peripheral blood mononuclear cells were obtained, and their cytokine production was quantified after incubation with pathogen-associated molecular patterns isolated from patients’ biopsies and compared with healthy controls. Results: β-diversity analysis showed statistically significant differences regarding bacteria comparing follicular microbiota of healthy and FD-affected hairs. Ruminococcaceae, Agathobacter sp., Tyzzerella sp., and Bacteriodales vadin HA21 family were good predictors of disease status. IL-10, TNF-α, and IL-6 levels were significantly decreased in patients after incubation with various strains of bacteria compared with controls.
Conclusion
FD hair follicles have a specific heterogenous follicular bacterial microbiota signature. Additionally, these patients seem to have an impaired immunological response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
- Trichology and Hair Transplantation Unit, Grupo Pedro Jaen Clinic, Madrid, Spain.
- Immunology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
- Microbiology Department, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
- Red Española de Investigación en Patología Infecciosa (REIPI), Madrid, Spain.
- Immunology Department, Ramon y Cajal University Hospital, Madrid, Spain.
Zitieren
APA
Moreno-Arrones, O. M., Garcia-Hoz, C., Del Campo, R., Roy, G., Saceda-Corralo, D., Jimenez-Cauhe, J., Ponce-Alonso, M., Serrano-Villar, S., Jaen, P., Paoli, J., & Vano-Galvan, S. (2023). Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response. Dermatology, 239(3), 454-461. https://doi.org/10.1159/000529301
Vancouver
Moreno-Arrones OM, Garcia-Hoz C, Del Campo R, Roy G, Saceda-Corralo D, Jimenez-Cauhe J, et al. Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response. Dermatology. 2023;239(3):454-461. doi:10.1159/000529301
BibTeX
@article{MorenoArrones2023,
author = {Moreno-Arrones, Oscar M and Garcia-Hoz, Carlota and Del Campo, Rosa and Roy, Garbiñe and Saceda-Corralo, David and Jimenez-Cauhe, Juan and Ponce-Alonso, Manuel and Serrano-Villar, Sergio and Jaen, Pedro and Paoli, John and Vano-Galvan, Sergio},
title = {Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response},
journal = {Dermatology},
year = {2023},
volume = {239},
number = {3},
pages = {454--461},
doi = {10.1159/000529301}
}
EUVIMED